UBE2D3 and cancer: UBE2D3 is mutated, and its expression level is altered in a wide variety of cancers, including breast, ovarian, cervical, head and neck and esophageal cancer, melanoma, leukemia, and multiple myeloma (Oncomine, EMBL-EBI Expression Atlas, Cosmic, and ICGC databases).